Minoxidil

米诺地尔

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameMinoxidil
Drug Alias NameMinoxidilum哌嘧啶二胺长压定降压定敏乐血定 +[17] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel agonists
TargetsVoltage-gated potassium channel
Therapy Area/IndicationsGenetic Predisposition to DiseaseVitiligoAlopecia +[7] 
Global Approved IndicationsAlopeciaHypertension
Approved Indications in ChinaAlopecia
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesRussian Federation +[13] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesKenvue Brands LlcSamson Clinical Operations Pty LtdAneira Pharma Inc +[13] 
Inactive CompaniesJohnson & Johnson Healthcare Products Division Of Mcneil-Ppc IncMerz Pharmaceuticals GmbhUniversity Of Minnesota +[13] 
Active IndicationsGenetic Predisposition to DiseaseVitiligoAlopecia +[6] 
Inactive IndicationsHypertension

Other Information

ATC CodeC02DC01D11AX01
Related LinksWikipediaDrugBankKEGG